Hyporesponsiveness of Natural Killer Cells and a Dysfunctional Inflammatory Response in Critically Ill Patients
NCT02565589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48
Last updated 2017-08-04
Summary
To investigate natural killer (NK) cell activities, circulating cytokine levels and peripheral blood mononuclear cell (PBMC) cytokine production status in critically ill patients.
Conditions
- Critical Illness
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2015-07-31
- Completion
- 2015-09-30
More Related Trials
-
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
NCT00823524 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
NK Cells Infusion for Advanced Malignancies
NCT03619954 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
NCT00909558 ·Status: SUSPENDED ·Phase: PHASE1
-
The Change of NK Cell Activity After Head and Neck Cancer Surgery
NCT02661776 ·Status: COMPLETED
-
The Role of NK Cells to Detect Blood Infection in ALL.
NCT06160115 ·Status: NOT_YET_RECRUITING
-
NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors
NCT05528341 ·Status: RECRUITING ·Phase: PHASE1
-
Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation
NCT02978274 ·Status: UNKNOWN
-
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
NCT02562963 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Neoantigen-expanded Autologous Immune Cell Therapy
NCT05020119 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Polyfunctionality of Anti-tumor T Lymphocytes in Cancerology: Potential Biomarker for Emerging Immunotherapies
NCT02880046 ·Status: UNKNOWN
-
Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma
NCT01240005 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
NK Cell Infusion for Patients With Acute Myeloid Leukemia
NCT04221971 ·Status: UNKNOWN ·Phase: PHASE1
-
Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD
NCT06568328 ·Status: RECRUITING ·Phase: PHASE1
-
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
NCT04960059 ·Status: COMPLETED
-
Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1
NCT02840058 ·Status: COMPLETED ·Phase: NA
-
Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors
NCT05976906 ·Status: UNKNOWN ·Phase: PHASE1
-
DC/NK Cell Therapy
NCT07202611 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of Blood and Follicular Fluid Immune Cell Constitution in Patients Undergoing in Vitro Fertilization
NCT01083745 ·Status: UNKNOWN
-
Transcriptomics Signature of Anti Vaccinia Memory B Cells
NCT02556489 ·Status: UNKNOWN
-
Uterine Natural Killer (uNK) Cell Expression in Patients With Repeated ICSI Failures: A Multicenter Cohort Study
NCT04867759 ·Status: RECRUITING
-
Serum Immunological Profiles in Head and Neck Cancer Patients Receiving Curative Radiotherapy
NCT03325036 ·Status: COMPLETED
-
A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes
NCT05371730 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation
NCT01853358 ·Status: COMPLETED ·Phase: PHASE1
-
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
NCT06509490 ·Status: RECRUITING ·Phase: NA
-
T Cell Response in Hypersensitivity Syndrome
NCT00213447 ·Status: COMPLETED